DVA DaVita Inc.

Montecito Acquires DaVita Building in Albuquerque

Montecito Medical Real Estate, a premier owner of medical office buildings throughout the U.S., has acquired the newly constructed DaVita Medical Group clinic in Albuquerque, N.M. Formerly known as ABQ Health Partners, DaVita Medical Group is one of the area's largest multi-specialty medical groups and is a division of DaVita, Inc. (NYSE:DVA), a leading provider of kidney-care services in the United States.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170419005469/en/

Sunport Healthcare Center in Albuquerque, N.M. (Photo: Business Wire)

Sunport Healthcare Center in Albuquerque, N.M. (Photo: Business Wire)

The 85,000-square-foot flagship Sunport Healthcare Center not only incorporates patient-centered design elements like soothing colors and music, but also features WELL Building Standards intended to promote healthy lifestyles for occupants.

For instance, in addition to the revolutionary floor plan with high ceilings, non-glare windows that maximize daylight, and a landscaped courtyard, the building offers scenic views from a spacious, inviting staircase to motivate people to be active. The 150 "teammates" who work in the building will enjoy a fitness area with locker rooms and showers; sit-stand desks in working spaces; and break rooms that double as gathering places with healthy-eating options.

“The innovative design of this new building incorporates DaVita's 'Trilogy of Care' and our approach of 'A Community First and A Company Second,'" said Arthur Richey, Senior Director of Development for DDP Team Genesis, of DaVita, Inc. "It fosters a positive relationship between doctors and their patients, which we believe is the key to great healthcare."

The two-story facility on nearly nine acres near the Albuquerque International Sunport boasts a radiology department with state-of-the-art ultrasound, CT and MRI imaging equipment and features the conveniences of a retail pharmacy and a café. In addition to a skin-care clinic and infusion therapy center, specialty providers include dermatologists, neurologists, pediatricians, podiatrists, rheumatologists and radiologists.

“We are thrilled to have worked with DaVita, Inc., a leading healthcare provider and consistently named by FORTUNE Magazine as one of the World’s Most Admired Companies,” said Chip Conk, CEO of Montecito Medical. “This asset complements our growing portfolio perfectly and we look forward to working with DaVita on other opportunities as they continue to grow their services throughout the U.S.”

Including the new DaVita building, Montecito Medical has acquired 30 medical office buildings since early 2015, representing more than $400 million and 1.46 million square feet.

EN
19/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DaVita Inc.

Davita Inc: 1 director

A director at Davita Inc sold 2,351 shares at 150.000USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Moody's Ratings assigns Ba3 rating to DaVita's proposed senior unsecur...

Moody's Ratings (Moody's) assigned a Ba3 rating to DaVita Inc.'s ("DaVita" or "the company") proposed senior unsecured notes. There is no change to the company's existing ratings, including the Ba2 corporate family rating (CFR), Ba2-PD probability of default rating (PDR), Ba1 senior secured bank cre...

DaVita Inc.: Update to credit analysis

Our credit view of this issuer reflects its strong free cash flow and its considerable scale and strong US market position, against its track record of debt-funded share repurchases.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of DaVita Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 15 January 2025 in which we reassessed the appropriateness of the ratings in the context of the...

Moody's Ratings assigns Ba3 rating to DaVita's proposed senior unsecur...

Moody's Ratings (Moody's) assigned a Ba3 rating to DaVita Inc.'s ("DaVita" or "the company") proposed offering of $1 billion senior unsecured notes. There is no change to the company's existing ratings, including the Ba2 corporate family rating (CFR), Ba2-PD probability of default rating (PDR), Ba1 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch